Epidemiology of Bloodstream Infections and Impact of Antibiotic Prophylaxis: A 10-Year Experience at a Tertiary Care Pediatric Oncology-Hematology Center in Italy

Bloodstream infections (BSIs) are a leading cause of morbidity and mortality in pediatric oncology-hematology patients. The local epidemiological landscape varies across centers, requiring continuous institutional surveillance. BSI episodes at a tertiary pediatric oncology-hematology center (Bari, Italy) were retrospectively reviewed over 10 years (2014 to 2024), analyzing microbiological spectrum, antimicrobial susceptibility, and the impact of 2 prophylactic policies: amoxicillin-clavulanate prophylaxis (2014 to 2019) versus its discontinuation (2019 to 2024). Among 568 newly diagnosed patients, 208 BSIs were documented in 144 (25.4%), with 93.8% monomicrobial. Gram-positive organisms predominated (61.6%), with coagulase-negative staphylococci as the most frequent isolates. Escherichia coli was the leading Gram-negative pathogen (9.5%). Eight fungal BSIs occurred exclusively in hematologic malignancies, half caused by Candida parapsilosis ; 2 were polymicrobial. Peak C-reactive protein independently predicted Gram-negative BSI in multivariable analysis (OR: 1.005; 95% CI: 1.001-1.010; P <0.05), with limited discriminatory performance (AUC: 0.62). Blood culture positivity was significantly higher during prophylaxis (5.75% vs. 3.65%; P <0.001). Multidrug-resistant organisms remained rare (3.8%), with no methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci detected. BSI-related mortality was 1.4%, confined to Gram-negative and fungal episodes. Prophylaxis discontinuation was associated with lower positivity rates. An empirical escalation strategy ensured adequate coverage while minimizing antibiotic exposure, supporting its use in this setting.

Authors

Institutions

Publication Details

Journal
Journal of Pediatric Hematology/Oncology
Published
2026-11-17
DOI
https://doi.org/10.1097/mph.0000000000003323
Primary Topic
Neutropenia and Cancer Infections
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Epidemiology of Bloodstream Infections and Impact of Antibiotic Prophylaxis: A 10-Year Experience at a Tertiary Care Pediatric Oncology-Hematology Center in Italy

Elio Castagnola, Nicola Santoro, Francesco De Leonardis, Luigi Ronga et al.
Journal of Pediatric Hematology/Oncology
Neutropenia and Cancer Infections
article

Epidemiology of Bloodstream Infections and Impact of Antibiotic Prophylaxis: A 10-Year Experience at a Tertiary Care Pediatric Oncology-Hematology Center in Italy

Elio Castagnola, Nicola Santoro, Francesco De Leonardis, Luigi Ronga, Paola Muggeo, Chiara Novielli, Maria Chironna, Roberta Koronica, Valentina Erroi, Roberta Rando
article en

Abstract

Bloodstream infections (BSIs) are a leading cause of morbidity and mortality in pediatric oncology-hematology patients. The local epidemiological landscape varies across centers, requiring continuous institutional surveillance. BSI episodes at a tertiary pediatric oncology-hematology center (Bari, Italy) were retrospectively reviewed over 10 years (2014 to 2024), analyzing microbiological spectrum, antimicrobial susceptibility, and the impact of 2 prophylactic policies: amoxicillin-clavulanate prophylaxis (2014 to 2019) versus its discontinuation (2019 to 2024). Among 568 newly diagnosed patients, 208 BSIs were documented in 144 (25.4%), with 93.8% monomicrobial. Gram-positive organisms predominated (61.6%), with coagulase-negative staphylococci as the most frequent isolates. Escherichia coli was the leading Gram-negative pathogen (9.5%). Eight fungal BSIs occurred exclusively in hematologic malignancies, half caused by Candida parapsilosis ; 2 were polymicrobial. Peak C-reactive protein independently predicted Gram-negative BSI in multivariable analysis (OR: 1.005; 95% CI: 1.001-1.010; P <0.05), with limited discriminatory performance (AUC: 0.62). Blood culture positivity was significantly higher during prophylaxis (5.75% vs. 3.65%; P <0.001). Multidrug-resistant organisms remained rare (3.8%), with no methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci detected. BSI-related mortality was 1.4%, confined to Gram-negative and fungal episodes. Prophylaxis discontinuation was associated with lower positivity rates. An empirical escalation strategy ensured adequate coverage while minimizing antibiotic exposure, supporting its use in this setting.

Journal of Pediatric Hematology/Oncology
Istituto Giannina Gaslini (IT), Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT), Ospedale Pediatrico Giovanni XXIII (IT), University of Bari Aldo Moro (IT)
Neutropenia and Cancer Infections
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon